http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2021106814-A4
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_311159e9645e7b312c4272609ac1e08d |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-102 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2840-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-84 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y106-02004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0042 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-815 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-84 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-02 |
| filingDate | 2021-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50fdc428603a7aec200ae8c387a42953 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_455c17b55bdc6569a705785b4f317a76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f2856fea0300e008de05f94ab49243a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23baae4789d5d6539f807e63fd82f71b |
| publicationDate | 2021-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2021106814-A4 |
| titleOfInvention | Recombinant Vector Co-Expressing CPR And CYP9A12 And Its Preparation Method |
| abstract | of Descriptions nThe present invention discloses a recombinant vector co-expressing the CPR and CYP9A12 ngenes. The recombinant vector contains the CPR gene, small peptide 2A-Sig sequence and nCYP9A12 gene. The nucleotide sequence of the CPR gene is as shown in SEQ ID NO:1, and the nnucleotide sequence of the small peptide 2A-Sig sequence is as shown in SEQ ID NO:2, the nnucleotide sequence of the CYP9A12 gene is as shown in SEQ ID NO:3. The preparation method nis also provided. The beneficial effects of the present invention are as follows: the recombinant nvector co-expressing the CPR and CYP9A12 genes and the preparation method thereof are nprovided for the biodegradation of gossypol by the cytochrome P450-CYP9A12 microsomal nenzyme of Helicoverpa armigera in vitro. The gossypol degrading enzyme added externally can be nused to reduce the content of gossypol in the cottonseed meal, so as to increase the dosage of the ncottonseed meal in the feed formula. |
| priorityDate | 2021-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 370.